We are live on ! Find out more
ATRS

Antares Pharma, Inc.

Delisted

ATRS was delisted on the 23rd of May, 2022.

171 hedge funds and large institutions have $339M invested in Antares Pharma, Inc. in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 47 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 47

17% more capital invested

Capital invested by funds: $291M → $339M (+$48.3M)

10% more call options, than puts

Call options by funds: $1.18M | Put options by funds: $1.07M

8% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 24

2% less funds holding

Funds holding: 174171 (-3)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
171
Holders Change
-3
Holders Change %
-1.72%
% of All Funds
3%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
22
Increased
55
Reduced
47
Closed
24
Calls
$1.18M
Puts
$1.07M
Net Calls
+$110K
Net Calls Change
+$963K
Name Holding Trade Value Shares
Change
Change in
Stake
State Board of Administration of Florida Retirement System
26
State Board of Administration of Florida Retirement System
Florida
$2.48M +$2.35M +543,430 +918%
PCM
27
Perkins Capital Management
Minnesota
$2.23M +$267K +61,500 +13%
Deutsche Bank
28
Deutsche Bank
Germany
$2.19M +$1.53M +354,060 +199%
State of New Jersey Common Pension Fund D
29
State of New Jersey Common Pension Fund D
New Jersey
$2.11M +$2.22M +512,392 New
AQR Capital Management
30
AQR Capital Management
Connecticut
$2.06M -$818K -188,872 -27%
HVC
31
Healthcare Value Capital
New Jersey
$2.06M
Millennium Management
32
Millennium Management
New York
$1.93M +$1.77M +407,915 +663%
Swiss National Bank
33
Swiss National Bank
Switzerland
$1.49M +$23K +5,300 +1%
RMCM
34
Reynders McVeigh Capital Management
Massachusetts
$1.48M +$460K +106,068 +42%
Wells Fargo
35
Wells Fargo
California
$1.39M -$408K -94,075 -22%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$1.37M
BGIM
37
Brandywine Global Investment Management
Pennsylvania
$1.24M -$11.9K -2,735 -0.9%
AC
38
Avenir Corporation
Virginia
$1.24M
ECM
39
ExodusPoint Capital Management
New York
$1.2M +$1.26M +291,076 New
BAS
40
Brown Advisory Securities
Maryland
$1.13M
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$1.1M -$59.3K -13,680 -5%
Goldman Sachs
42
Goldman Sachs
New York
$1.09M -$2.25M -519,450 -66%
MSL
43
Mackay Shields LLC
New York
$1.05M -$733K -169,200 -40%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$1.02M -$6.17K -1,425 -0.6%
Invesco
45
Invesco
Georgia
$999K +$9.54K +2,202 +0.9%
Bank of America
46
Bank of America
North Carolina
$945K +$113K +26,092 +13%
Baird Financial Group
47
Baird Financial Group
Wisconsin
$838K
OAM
48
Oberweis Asset Management
Illinois
$824K
RJA
49
Raymond James & Associates
Florida
$820K +$104K +24,073 +14%
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$791K -$320K -73,774 -28%

ATRS Hedge Fund Activity: Q1 2021 in Review

171 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q1 2021, worth a combined $339M — up 17% from $291M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of ATRS and 22 opened new positions — a net loss of 2 holders — while 47 trimmed existing stakes and 55 added.

The largest buyer was Rubric Capital Management (New York), adding an estimated $22.3M. The largest seller was HealthInvest Partners, exiting entirely with an estimated $6.86M sold.

  • 171 institutional investors held Antares Pharma, Inc. (ATRS) as of Q1 2021, down from 174 in Q4 2020.
  • Funds reported $339M of Antares Pharma, Inc. stock for Q1 2021, up 17% quarter-over-quarter.
  • 22 funds opened new Antares Pharma, Inc. positions in Q1 2021 and 24 closed out, a net change of -2 holders.
  • The largest Antares Pharma, Inc. buyer in Q1 2021 was Rubric Capital Management (New York), an estimated $22.3M added.
  • The largest Antares Pharma, Inc. seller in Q1 2021 was HealthInvest Partners, an estimated $6.86M sold.

Based on aggregated 13F filings for Q1 2021.